170229 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; DNA viruses Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
Method for Evaluating Sample Containing Virus Particles, Device for Evaluating Sample Containing Virus Particles and Program for Evaluating Sample Containing Virus Particles
#2Method for separating full and empty AAV particles
#3ADENO-ASSOCIATED VIRUS VECTORS EMPTY/FULL RATIO ANALYSIS USING CE-BASED GENOME AND CAPSID QUANTIFICATION
#4Methods of Evaluating Virus-Producing Cells
#5CHARACTERIZATION OF ADENO-ASSOCIATED VIRUS USING MICROCHIP CAPILLARY ELECTROPHORESIS
#6METHODS FOR PROCESSING AND ANALYZING VIRUS CAPSID PROTEINS
#7METHOD OF CHARACTERIZING A RECOMBINANT VIRUS
#8METHOD FOR HOST CELL PROTEIN IDENTIFICATION IN BIOTHERAPEUTIC SAMPLES
#9METHODS OF LOADING A STREPTAVIDIN COLUMN WITH BIOTINYLATED AFFINITY AGENTS
#10METHODS FOR PURIFICATION, DETECTION AND QUANTIFICATION OF RESIDUAL PEI-BASED TRANSFECTION REAGENTS
#11METHODS FOR QUANTITATING VIRAL CAPSIDS
#12METHOD FOR DETERMINING FULL CAPSID CONTENT IN ADENOASSOCIATED VIRUSES
#13METHODOLOGY TO CHARACTERIZE EMPTY-FULL RATIO IN CRUDE AAV SAMPLES
#14METHOD FOR DETERMINING DNA CONCENTRATION IN DNA VIRUS
#15HOST CELL PROTEIN ANALYSIS FOR ADENO-ASSOCIATED VIRUS (AAV)-BASED GENE THERAPY
#16METHOD AND KIT FOR RAPIDLY DETECTING VIRAL GENOME SIZE
#17LABELING AND ANTI-DRUG ANTIBODY ASSAYS FOR AAV VECTORS
#18METHOD FOR IDENTIFYING AMINO ACID SITE IN PROTEIN, TO WHICH SUGAR IS BONDED, AND KIT
#19METHODS OF LOADING A STREPTAVIDIN COLUMN WITH BIOTINYLATED AFFINITY AGENTS
#20METHOD AND SYSTEM FOR MEASURING CELL-MEDIATED IMMUNITY TO ADENO-ASSOCIATED-VIRUS INFECTION
#21Method for the detection and quantification of adeno-associated viruses (AAVs) using an affinity matrix
#22METHODS FOR DETECTING AND EVALUATING VIRUSES AND VIRUS-LIKE PARTICLES
#23NOVEL HUMAN ERYTHROID PROGENITOR CELL LINE HIGHLY PERMISSIVE TO B19 INFECTION AND USES THEREOF
#24METHODS AND KITS FOR QUANTIFYING THE REMOVAL OF MOCK VIRUS PARTICLES FROM A PURIFIED SOLUTION
#25Adeno-Associated Virus Factor VIII Vectors, Associated Viral Particles and Therapeutic Formulations Comprising the Same
#26NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO
#27VIRUS-LIKE PARTICLE BINDING AGENTS, RELATED COMPOSITIONS, AND RELATED METHODS
#28Liquid Chromatography Assay for Determining AAV Capsid Ratio
#29Methods for Viral Particle Characterization Using Two-Dimensional Liquid Chromatography-Mass Spectrometry
#30Characterization of adeno-associated virus using microchip capillary electrophoresis
#31Recombinant porcine parvovirus antigenic protein and use thereof
#32Assays for detecting analytes in samples and kits and compositions related thereto
#33MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES
#34Murine parvovirus and uses thereof
#35Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
#36METHODS FOR DETERMINING POTENCY OF ADENO-ASSOCIATED VIRUS PREPARATIONS
#37Methods and kits for quantifying the removal of mock virus particles from a purified solution
#38Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy
#39Method and kit for simultaneously detecting human parvovirus B19 antigen and antibody
#40METHOD FOR DETECTING INFECTIOUS PARVOVIRUS IN PHARMACEUTICAL PREPARATIONS
#41ALKALINE PRETREATMENT OF PARVOVIRUSES FOR IMMUNOASSAYS
#42Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
#43Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
#44Methods for evaluating viral clearance from a process solution employing mock viral particles
#45Assays for detecting analytes in samples and kits and compositions related thereto
#46ELIMINATION OF PATHOGENIC INFECTION IN FARMED ANIMAL POPULATIONS
#47Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
#48Mutated parvovirus structural proteins as vaccines
#49Method of determining virus removal from a sample containing a target protein using activated carbon
#50Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof
#51SINGLE STEP CALIBRATION CURVE THROUGH SAMPLE CONVECTION
#52Porcine parvovirus 5B, methods of use and vaccine
#53Parvovirus Vp1 unique region polypeptides and compositions thereof
#54Antibody detection method and device for a saliva sample from a non-human animal
#55Antibody that binds to H-1 parvovirus
#56Vaccines containing canine parvovirus genetic variants
#57Human bocavirus and methods of diagnosis and treatment
#58NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO
#59COMPOSITIONS AND PROCESSES RELATING TO HUMAN BOCAVIRUS
#60MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES
#61Simple Tests for Rapid Detection of Canine Parvovirus Antigen and Antibodies
#62METHOD FOR DETECTING HUMAN PARVOVIRUS ANTIGEN
#63Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy
#64Method for detecting infectious parvovirus in pharmaceutical preparations
#65Vaccines containing canine parvovirus genetic variants
#66Methods for detecting parvovirus infections
#67Methods and compounds to alter virus infection
#68Vaccines containing canine parvovirus genetic variants
#69Human and methods of diagnosis and treatment
#70Methods and compounds to alter virus infection
#71Compounds and methods to enhance rAAV transduction
#72Methods for detecting parvovirus infections
#73Compounds and methods to enhance rAAV transduction